tiprankstipranks
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
Holding GYRE?
Track your performance easily

Gyre Therapeutics (GYRE) Stock Investors

799 Followers
Based on 775,913 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GYRE
On average, investors allocate 0.00% of their portfolios to GYRE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 775,913 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding GYRE

3.4%
Last 7
Days
4.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GYRE, out of 775,913 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

GYRE Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,798 investors who made their portfolios public
The table shows changes in GYRE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

GYRE Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.13%
-0.94%
-2.74%
34.70B
Consumer Cyclical
Plug Power
5.20%
-1.71%
-3.60%
2.10B
Industrials
Viking Therapeutics
4.20%
-1.33%
-1.16%
4.62B
Healthcare
Li Auto
5.54%
-1.69%
-7.04%
23.27B
Consumer Cyclical
Nio
9.43%
-1.60%
-3.47%
9.24B
Consumer Cyclical
Lucid Group
5.70%
-1.05%
-1.31%
7.92B
Consumer Cyclical
Block
4.17%
-0.84%
+2.59%
54.32B
Technology
JD
5.01%
-1.60%
+0.19%
57.98B
Consumer Cyclical
Carnival
6.21%
+0.97%
+5.23%
31.57B
Consumer Cyclical
Bristol-Myers Squibb
3.49%
+1.05%
-0.29%
114.19B
Healthcare
Based on the activity of 775,913 active portfolios
Open your Smart Portfolio

GYRE Investor Analysis

GYRE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
7.0%
of GYRE holders
are under 35
Average Segment Performance
Average P/E Ratio31.68
Beta11.04
Dividend Yield194.55%
GYRE investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
57.4%
of GYRE holders
are between 35–55
Average Segment Performance
Average P/E Ratio28.42
Beta21.20
Dividend Yield87.23%
GYRE investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
35.7%
of GYRE holders
are over 55
Average Segment Performance
Average P/E Ratio26.67
Beta9.52
Dividend Yield151.99%
Overview of age group and performance of GYRE stock investors
See who invests in GYRE according to age group and performance.

FAQ

How many retail Investors hold GYRE?
<0.1% of TipRanks' retail investors hold GYRE in their portfolios.
    What is GYRE Investor Sentiment?
    GYRE’s Investor Sentiment is Negative.
      What percentage of retail investors changed their holding of GYRE in the last 7 days?
      ▲ 3.4% of TipRanks' retail investors changed their holding of GYRE in the last 7 days.
        What percentage of retail investors changed their holding of GYRE in the last 30 days?
        ▼ 4.6% of TipRanks' retail investors changed their holding of GYRE in the last 30 days.
          What is the average age of retail investors who hold GYRE?
          The average age of GYRE Holders is between 35–55.
            What other stocks have GYRE investors also bought?
            GYRE Investors also bought DKNG, PLUG, VKTX, LI, NIO, LCID, SQ, JD, CCL, BMY.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              BDXBecton Dickinson
              LCTXLineage Therap
              EXASExact Sciences
              HALOHalozyme
              JAZZJazz Pharmaceuticals
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis